The AstraZeneca vaccine has been proven to be an effective tool in combating the Covid-19 pandemic, according to health authorities. Despite concerns raised by AstraZeneca’s admission that the vaccine could cause blood clots in rare instances, experts have stated that the risk of this occurring is extremely rare, typically within 42 days of vaccination.
Thuong reassured the public that blood clots are a rare side effect of the Covid-19 vaccine and can be effectively treated. He urged people not to fear receiving the vaccine, emphasizing its importance in protecting against severe illness and death from Covid-19. Khanh echoed this sentiment, explaining that blood clotting issues can arise in various clinical situations, including Covid-19 infection, and are not solely linked to vaccination.
The European Medicines Agency has recommended the continued use of the AstraZeneca vaccine, highlighting the importance of consultation, detection, and treatment of possible complications that may arise. In light of AstraZeneca’s acknowledgment of potential blood clotting side effects, experts believe that this recognition will guide future vaccine research and development, prompting closer attention to potential adverse effects in future vaccination efforts.
